000137593 001__ 137593
000137593 005__ 20240229105111.0
000137593 0247_ $$2doi$$a10.7554/eLife.36967
000137593 0247_ $$2pmid$$apmid:30179157
000137593 0247_ $$2pmc$$apmc:PMC6133554
000137593 0247_ $$2altmetric$$aaltmetric:47658243
000137593 037__ $$aDKFZ-2018-01473
000137593 041__ $$aeng
000137593 082__ $$a500
000137593 1001_ $$0P:(DE-He78)761f5d0f73e0d8f170394b29448a9e8d$$aKather, Jakob Nikolas$$b0$$eFirst author
000137593 245__ $$aTopography of cancer-associated immune cells in human solid tumors.
000137593 260__ $$aCambridge$$beLife Sciences Publications$$c2018
000137593 3367_ $$2DRIVER$$aarticle
000137593 3367_ $$2DataCite$$aOutput Types/Journal article
000137593 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1659956941_8495
000137593 3367_ $$2BibTeX$$aARTICLE
000137593 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000137593 3367_ $$00$$2EndNote$$aJournal Article
000137593 520__ $$aLymphoid and myeloid cells are abundant in the tumor microenvironment, can be quantified by immunohistochemistry and shape the disease course of human solid tumors. Yet, there is no comprehensive understanding of spatial immune infiltration patterns (topography) across cancer entities and across various immune cell types. In this study, we systematically measure the topography of multiple immune cell types in 965 histological tissue slides from N = 177 patients in a pan-cancer cohort. We provide a definition of inflamed (hot), non-inflamed (cold) and immune excluded patterns and investigate how these patterns differ between immune cell types and between cancer types. In an independent cohort of N = 287 colorectal cancer patients, we show that hot, cold and excluded topographies for effector lymphocytes (CD8) and tumor-associated macrophages (CD163) alone are not prognostic, but that a bivariate classification system can stratify patients. Our study adds evidence to consider immune topographies as biomarkers for patients with solid tumors.
000137593 536__ $$0G:(DE-HGF)POF3-314$$a314 - Tumor immunology (POF3-314)$$cPOF3-314$$fPOF III$$x0
000137593 588__ $$aDataset connected to CrossRef, PubMed,
000137593 7001_ $$0P:(DE-He78)7eaaf5131f5096c7ff7de12dde4ceca5$$aSuarez-Carmona, Meggy$$b1
000137593 7001_ $$0P:(DE-He78)8dde8d3920dc06c59314abdb4ac7d2e8$$aCharoentong, Pornpimol$$b2
000137593 7001_ $$aWeis, Cleo-Aron$$b3
000137593 7001_ $$aHirsch, Daniela$$b4
000137593 7001_ $$00000-0003-4851-8813$$aBankhead, Peter$$b5
000137593 7001_ $$00000-0003-1468-4645$$aHorning, Marcel$$b6
000137593 7001_ $$aFerber, Dyke$$b7
000137593 7001_ $$00000-0002-1221-7114$$aKel, Ivan$$b8
000137593 7001_ $$aHerpel, Esther$$b9
000137593 7001_ $$aSchott, Sarah$$b10
000137593 7001_ $$0P:(DE-He78)e00d6a13ce5ea2af7bde67bac1319dd3$$aZörnig, Inka$$b11
000137593 7001_ $$0P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3$$aUtikal, Jochen$$b12
000137593 7001_ $$aMarx, Alexander$$b13
000137593 7001_ $$aGaiser, Timo$$b14
000137593 7001_ $$0P:(DE-HGF)0$$aBrenner, Herrmann$$b15
000137593 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b16
000137593 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b17
000137593 7001_ $$0P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1$$aJäger, Dirk$$b18
000137593 7001_ $$0P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601$$aHalama, Niels$$b19$$eLast author
000137593 773__ $$0PERI:(DE-600)2687154-3$$a10.7554/eLife.36967$$gVol. 7, p. e36967$$pe36967$$teLife$$v7$$x2050-084X$$y2018
000137593 909CO $$ooai:inrepo02.dkfz.de:137593$$pVDB
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)761f5d0f73e0d8f170394b29448a9e8d$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7eaaf5131f5096c7ff7de12dde4ceca5$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8dde8d3920dc06c59314abdb4ac7d2e8$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e00d6a13ce5ea2af7bde67bac1319dd3$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000137593 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000137593 9131_ $$0G:(DE-HGF)POF3-314$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTumor immunology$$x0
000137593 9141_ $$y2018
000137593 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bELIFE : 2015
000137593 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000137593 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000137593 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000137593 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000137593 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000137593 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000137593 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000137593 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000137593 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000137593 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000137593 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bELIFE : 2015
000137593 9201_ $$0I:(DE-He78)D120-20160331$$kD120$$lD120 Angewandte Tumor-Immunität$$x0
000137593 9201_ $$0I:(DE-He78)G300-20160331$$kG300$$lKKE Dermatoonkologie$$x1
000137593 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x2
000137593 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x3
000137593 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x4
000137593 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x5
000137593 980__ $$ajournal
000137593 980__ $$aVDB
000137593 980__ $$aI:(DE-He78)D120-20160331
000137593 980__ $$aI:(DE-He78)G300-20160331
000137593 980__ $$aI:(DE-He78)C020-20160331
000137593 980__ $$aI:(DE-He78)C070-20160331
000137593 980__ $$aI:(DE-He78)G110-20160331
000137593 980__ $$aI:(DE-He78)L101-20160331
000137593 980__ $$aUNRESTRICTED